Showing results (31-40 of 1,026) with videos related to
Sort By:
Pageof 103
Current Oncology Reports|February 9, 2006
Correlative studies in neuro-oncology trials: should they influence treatment?Monika E Hegi, Roger StuppSeminars in Oncology|February 7, 2004
Radiotherapy in low-grade gliomas: ConsRené O Mirimanoff, Roger StuppThe Oncologist|February 16, 2006
Changing paradigms--an update on the multidisciplinary management of malignant gliomaRoger Stupp, Monika E Hegi, Martin J van den Bent, et al.Neuro-Oncology Advances|August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastomaKatharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.Neuro-Oncology Practice|March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.Neuro-Oncology|March 21, 2022
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastomaEmilie Le Rhun, Felix Boakye Oppong, Maureen Vanlancker, et al.Acta Neurologica Belgica|February 26, 2009
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomideBart Neyns, Anne Hoorens, Roger StuppChinese Clinical Oncology|April 6, 2015
The changing world of drug development: an academic research organization's perspective on the "Seven Wonders" of the future world of anticancer drug developmentYan Liu, Denis Lacombe, Roger StuppAnnals of Medicine|December 3, 2003
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityCurzio Rüegg, Jelena Zaric, Roger StuppEuropean Journal of Cancer (Oxford, England : 1990)|July 24, 2018
Associations of anticoagulant use with outcome in newly diagnosed glioblastomaEmilie Le Rhun, Els Genbrugge, Roger Stupp, et al.Pageof 103